Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Current Assets (2018 - 2025)

Historic Current Assets for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $51.7 million.

  • Precision Biosciences' Current Assets fell 5321.79% to $51.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.7 million, marking a year-over-year decrease of 5321.79%. This contributed to the annual value of $95.0 million for FY2024, which is 3033.9% down from last year.
  • According to the latest figures from Q3 2025, Precision Biosciences' Current Assets is $51.7 million, which was down 5321.79% from $70.3 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Current Assets ranged from a high of $247.7 million in Q2 2022 and a low of $51.7 million during Q3 2025
  • In the last 5 years, Precision Biosciences' Current Assets had a median value of $147.9 million in 2023 and averaged $151.2 million.
  • In the last 5 years, Precision Biosciences' Current Assets surged by 5322.84% in 2021 and then tumbled by 5321.79% in 2025.
  • Precision Biosciences' Current Assets (Quarter) stood at $161.8 million in 2021, then grew by 23.09% to $199.1 million in 2022, then tumbled by 31.51% to $136.4 million in 2023, then crashed by 30.34% to $95.0 million in 2024, then plummeted by 45.57% to $51.7 million in 2025.
  • Its last three reported values are $51.7 million in Q3 2025, $70.3 million for Q2 2025, and $82.1 million during Q1 2025.